We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties. You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies. In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Texas Capital's Growth Strategies Aid Financials Amid Rising Expenses
Read MoreHide Full Article
Texas Capital Bancshares, Inc. (TCBI - Free Report) continues to execute its strategies to enhance top-line growth. Its steady loan growth will continue to support its financials. Given the company's strong liquidity position, its capital distribution activities seem sustainable. However, an elevated expense base and deteriorating asset quality are major concerns.
Key Factors Driving Growth of Texas Capital
Strategic Plan: TCBI is progressing well with its strategies announced in 2021 to improve operating efficiency. Pursuant to this, Texas Capital agreed to purchase a portfolio of about $400 million in committed exposure to healthcare companies. This acquisition is part of TCBI's multi-year attempt to expand its corporate banking and healthcare vertical.
The company continues to progress with investment banking offerings every quarter, and build a base of consistent and repeatable revenues that will be a differentiator in the marketplace and a meaningful contributor to earnings.
Strong Balance Sheet Position: Balance sheet strength has been a key positive for Texas Capital and it continues to demonstrate resilience on a variety of metrics despite a tough operating backdrop. In 2024, net loans held for investments improved 5% year over year to $17.23 billion. Also, total deposits increased 13% year over year to $25.23 billion.
As of Dec. 31, 2024, Texas Capital had a total debt (comprising long-term debt and short-term borrowings) of $1.55 billion. The company’s liquid assets (including its cash and due from banks, and interest-bearing cash and cash equivalents) as of the same date were $3.18 billion. Given the decent liquidity position, its debt seems manageable.
Capital Distribution Update: TCBI is considered well-capitalized as its capital ratios are exceptionally strong compared with its peer group. These ratios have enhanced with the additional capital raised since 2008. As of Dec. 31, 2024, the total capital ratio and common equity tier (CET) 1 ratio were 15.1% and 11.4%, respectively. These ratios are well above the regulatory requirement.
On Jan. 22, 2025, the company’s board of directors authorized a share repurchase program under which it may repurchase up to $200 million in shares of its outstanding common stock through Jan. 31, 2026. Supported by decent capital levels and liquidity position, the company’s share repurchase program seems sustainable.
Near-Term Headwinds for TCBI
Escalating Expenses: Texas Capital continues to see a persistent rise in non-interest expenses over the past few years. The metric witnessed a CAGR of 42.2% over the last four years (2020-2024). This is due to the company’s efforts to make technological investments leading to structural improvements and focus on increasing efficiency. These moves might boost Texas Capital’s growth in the long term, but the rising expense level is limiting the near-term bottom-line expansion.
Worsening Credit Quality: Deterioration in credit quality remains a headwind for Texas Capital. The company’s non-performing assets and net charge-offs (NCOs) have seen an elevated graph in 2019, 2020, 2022 and 2023. NCOs witnessed a decline in 2024, while non-performing assets remained high. Going forward, the increase in criticized assets within the real estate sector due to multi-family and office loans will keep the metric high in the upcoming period.
TCBI's Price Performance & Zacks Rank
Shares of this Zacks Rank #3 (Hold) company have gained 39.3% compared with the industry’s growth of 23.9% in the past six months.
Image Source: Zacks Investment Research
Finance Stocks Worth Considering
Some better-ranked peers of TCBI are BancFirst Corporation (BANF - Free Report) and Cullen/Frost Bankers (CFR - Free Report) .
Estimates for BANF’s current-year earnings have been unchanged over the past week. The company’s shares have jumped 24.3% in the past six months. It currently flaunts a Zacks Rank of 1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Estimates for CFR’s current-year earnings have been revised upward in the past week. The company’s shares have gained 33.5% in the past six months. It currently carries a Zacks Rank of 1.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Texas Capital's Growth Strategies Aid Financials Amid Rising Expenses
Texas Capital Bancshares, Inc. (TCBI - Free Report) continues to execute its strategies to enhance top-line growth. Its steady loan growth will continue to support its financials. Given the company's strong liquidity position, its capital distribution activities seem sustainable. However, an elevated expense base and deteriorating asset quality are major concerns.
Key Factors Driving Growth of Texas Capital
Strategic Plan: TCBI is progressing well with its strategies announced in 2021 to improve operating efficiency. Pursuant to this, Texas Capital agreed to purchase a portfolio of about $400 million in committed exposure to healthcare companies. This acquisition is part of TCBI's multi-year attempt to expand its corporate banking and healthcare vertical.
The company continues to progress with investment banking offerings every quarter, and build a base of consistent and repeatable revenues that will be a differentiator in the marketplace and a meaningful contributor to earnings.
Strong Balance Sheet Position: Balance sheet strength has been a key positive for Texas Capital and it continues to demonstrate resilience on a variety of metrics despite a tough operating backdrop. In 2024, net loans held for investments improved 5% year over year to $17.23 billion. Also, total deposits increased 13% year over year to $25.23 billion.
As of Dec. 31, 2024, Texas Capital had a total debt (comprising long-term debt and short-term borrowings) of $1.55 billion. The company’s liquid assets (including its cash and due from banks, and interest-bearing cash and cash equivalents) as of the same date were $3.18 billion. Given the decent liquidity position, its debt seems manageable.
Capital Distribution Update: TCBI is considered well-capitalized as its capital ratios are exceptionally strong compared with its peer group. These ratios have enhanced with the additional capital raised since 2008. As of Dec. 31, 2024, the total capital ratio and common equity tier (CET) 1 ratio were 15.1% and 11.4%, respectively. These ratios are well above the regulatory requirement.
On Jan. 22, 2025, the company’s board of directors authorized a share repurchase program under which it may repurchase up to $200 million in shares of its outstanding common stock through Jan. 31, 2026. Supported by decent capital levels and liquidity position, the company’s share repurchase program seems sustainable.
Near-Term Headwinds for TCBI
Escalating Expenses: Texas Capital continues to see a persistent rise in non-interest expenses over the past few years. The metric witnessed a CAGR of 42.2% over the last four years (2020-2024). This is due to the company’s efforts to make technological investments leading to structural improvements and focus on increasing efficiency. These moves might boost Texas Capital’s growth in the long term, but the rising expense level is limiting the near-term bottom-line expansion.
Worsening Credit Quality: Deterioration in credit quality remains a headwind for Texas Capital. The company’s non-performing assets and net charge-offs (NCOs) have seen an elevated graph in 2019, 2020, 2022 and 2023. NCOs witnessed a decline in 2024, while non-performing assets remained high. Going forward, the increase in criticized assets within the real estate sector due to multi-family and office loans will keep the metric high in the upcoming period.
TCBI's Price Performance & Zacks Rank
Shares of this Zacks Rank #3 (Hold) company have gained 39.3% compared with the industry’s growth of 23.9% in the past six months.
Finance Stocks Worth Considering
Some better-ranked peers of TCBI are BancFirst Corporation (BANF - Free Report) and Cullen/Frost Bankers (CFR - Free Report) .
Estimates for BANF’s current-year earnings have been unchanged over the past week. The company’s shares have jumped 24.3% in the past six months. It currently flaunts a Zacks Rank of 1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Estimates for CFR’s current-year earnings have been revised upward in the past week. The company’s shares have gained 33.5% in the past six months. It currently carries a Zacks Rank of 1.